85807308 - SYNTHETYX

Information

  • Trademark
  • 85807308
  • Serial Number
    85807308
  • Filing Date
    December 20, 2012
    12 years ago
  • Transaction Date
    November 07, 2013
    11 years ago
  • Status Date
    November 07, 2013
    11 years ago
  • Location Date
    November 07, 2013
    11 years ago
  • Status Code
    602
  • Current Location
    TMEG LAW OFFICE 102 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    KUYKENDALL, LINDSEY
  • Attorney Docket Number
    60895-342375
    Attorney Name
    Mark Harrison
    Law Office Assigned Location Code
    L20
  • Owners
Mark Drawing Code
4000
Mark Identification
SYNTHETYX
Case File Statements
  • GS0011: Human cells and isogenic cell lines for scientific, laboratory or medical research; genomic reference control samples for medical laboratory use; Molecular biology research tools, in the nature of biological and biochemical reagents, specifically, genomic DNA; DNA repair enzymes
  • GS0051: Biological and chemical reagents, including, genomic DNA, cell cultures and mutant and normal isogenic human cell line pairs, for research use; protein cell lysates, genomic DNA preparations and FFPE engineered tumor mimics for diagnostic use
  • GS0421: Custom cell-line engineering services; gene-editing services; DNA modeling services; gene engineering services; bio-technology, pharmaceutical and scientific testing, research, development, advice, consultancy and information services; biological research; biology and chemistry services; pharmaceutical research services; drug discovery services; research and development services for lead identification and validation; research and development services for target identification and validation; identification of patient-relevant drug targets; optimisation of drug candidates for clinical development; diagnostic services; medicinal and synthetic chemistry services; research and development services in the creation of libraries or collections of biologicals including cells and cell lines, chemicals and compounds; creating libraries or collections of normal and mutated genes; research and development services relating to targeting therapies to individuals; establishing patient genotypes; research and development services relating to combining therapies for individuals; research and development relating to reagents; disease modelling; design of clinical trials; research and development in re-positioning existing drugs from other therapeutic indications
  • PM0000: SYNTHETICS
Case File Event Statements
  • 11/7/2013 - 11 years ago
    8 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2
  • 11/7/2013 - 11 years ago
    7 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2
  • 4/11/2013 - 11 years ago
    6 - NON-FINAL ACTION MAILED Type: CNRT
  • 4/10/2013 - 11 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/8/2013 - 11 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/9/2013 - 11 years ago
    3 - NOTICE OF PSEUDO MARK MAILED Type: MPMK
  • 1/8/2013 - 11 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 12/24/2012 - 12 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP